Cirrus Therapeutics
PrivateLast Round
Seed
Oct 2, 2025
Total Funding Raised
$11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cirrus Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in October 2025.
Cirrus Therapeutics is a biotechnology company developing gene and cell therapies for ocular immunology to treat conditions like age-related macular degeneration (AMD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cirrus Therapeutics Comparables
Compare Cirrus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Complement Therapeutics GmbH | 84% | |
| Luxa Biotechnology | 81% | |
| Perceive Bio | 81% |
For institutional investors. Book with your work email.
Cirrus Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cirrus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Seed |
| ClavystBio | Seed |
| Polaris Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 562% MoM.
- Jun 27, 2026
Grew 33% QoQ, from 9 to 12 employees.
For institutional investors. Book with your work email.
Cirrus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cirrus Therapeutics's valuation, stock price, and market status.
Is Cirrus Therapeutics a public or private company?
Cirrus Therapeutics is a private company.
What is the current stock price of Cirrus Therapeutics?
Cirrus Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cirrus Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cirrus Therapeutics worth (valuation)?
Valuation information for Cirrus Therapeutics is not publicly available.
Can I buy Cirrus Therapeutics stock?
Cirrus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cirrus Therapeutics's last funding round?
Cirrus Therapeutics's most recent funding round was Seed on October 2, 2025.
Who are the main investors in Cirrus Therapeutics?
Key investors in Cirrus Therapeutics include ClavystBio.
Will Cirrus Therapeutics IPO soon?
No public IPO plans have been announced for Cirrus Therapeutics.
How can I track Cirrus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cirrus Therapeutics's shares on secondary markets.